BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Core Technology Behind Universal Detection Technology's ('UDTT') Anthrax Spore Monitor To Be Presented At The 106th Annual American Society for Microbiology Conference


5/22/2006 12:45:23 PM

LOS ANGELES, May 22 /PRNewswire-FirstCall/ -- Universal Detection Technology , a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats, announced today that the technology contained in UDTT's bacterial spore monitoring (BSM) device will be presented at the 106th annual American Society for Microbiology Conference held in Orlando, Florida on May 24.

The presentation, which will include recent developments and test results, will be given by Mr. Pun To Yung, a Caltech bioengineering graduate student at the Life Detection and Sample Handling Technologies Group at NASA's Jet Propulsion Laboratory (JPL). Mr. Yung's research is being supervised by Dr. Adrian Ponce, inventor of UDTT's licensed spore detection technology. UDTT licensed the technology from Caltech in 2001 and has developed BSM with support from JPL. Development of BSM-2000, which is currently available for commercial sale, has been spearheaded Dr. Ponce. Initial prototype of BSM-2000 was peer reviewed in the Institute for Electrical and Electronics Engineers' (IEEE) Engineering in Medicine and Biology Magazine.

"We feel honored that the core technology of the BSM-2000, which UDTT has licensed from Caltech, is being presented to the American Society for Microbiology, which is a leader in the advancement of microbiological research," said Amir Ettehadieh, UDTT's Director of Research and Development.

About American Society for Microbiology

The American Society for Microbiology is the largest single life science society, composed of over 42,000 scientists and health professionals. ASM's mission is to advance the microbiological sciences as a vehicle for understanding life processes and to apply and communicate this knowledge for the improvement of health and environmental and economic well-being worldwide. For more info go to http://www.asm.org

About Universal Detection Technology

Universal Detection Technology (UDTT), founded in 1973, is a developer of monitoring technologies, including bio-terrorism detection devices. Universal Detection Technology, in cooperation with NASA's Jet Propulsion Laboratory (JPL) has developed the BSM-2000, a bacterial spore and anthrax spore monitoring device, which combines JPL's spore detection technology with UDTT's aerosol capture device. For more information, please visit http://www.udetection.com.

Forward-Looking Statements

Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. These risks and uncertainties include, among other things, the funding of amounts of capital adequate to provide for our working capital needs and our timely repayment of debt; our ability to timely and cost effectively complete the development and testing of our products; our ability to commercially produce our products on a profitable basis; commercial acceptance of our products; product price volatility; product demand; market competition and general economic conditions and; other factors described in UDTT's filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

Universal Detection Technology

CONTACT: Jacques Tizabi of Universal Detection Technology,+1-310-248-3655, jtizabi@udetection.com; or Andrew Hellman of CEOcast,Inc., +1-212-732-4300, for Universal Detection Technology



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES